VaxLiant Overview
- Year Founded
-
2013
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
- Financing Rounds
-
2
VaxLiant General Information
Description
Developer of adjuvants intended to deliver vaccine's desired immune response. The company offers a portfolio of innovative ready-to-use and fully customizable adjuvants and provides unparalleled flexibility to help deliver antigens competitively as well as innovative antigen-delivery systems and technical support, thereby providing its customers the flexibility they need to develop and commercialize safe, effective vaccines.
Contact Information
Website
www.vaxliant.comCorporate Office
- 421 West Industrial Drive
- Lincoln, NE 68528
- United States
Corporate Office
- 421 West Industrial Drive
- Lincoln, NE 68528
- United States
VaxLiant Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
VaxLiant Patents
VaxLiant Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
JP-2018510874-A | Adjuvant compositions and related methods | Active | 24-Mar-2015 | ||
JP-2017537106-A | Adjuvant compositions and related methods | Active | 26-Nov-2014 |
VaxLiant FAQs
-
When was VaxLiant founded?
VaxLiant was founded in 2013.
-
Where is VaxLiant headquartered?
VaxLiant is headquartered in Lincoln, NE.
-
What industry is VaxLiant in?
VaxLiant’s primary industry is Pharmaceuticals.
-
Is VaxLiant a private or public company?
VaxLiant is a Private company.
-
What is VaxLiant’s current revenue?
The current revenue for VaxLiant is
.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »